Clinical Efficacy of Pneumococcal Conjugate 13-valent Vaccine in Young Children
Objective: Our aim was to study the clinical efficacy of pneumococcal conjugate 13-valent vaccine (PCV13) in children aged less than 3 years.Methods: retrospective comparative study of the incidence of acute respiratory infections (ARI), otitis and pneumonia during the first three years of life in 1...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Russo |
| Vydáno: |
Union of pediatricians of Russia
2016-12-01
|
| Edice: | Педиатрическая фармакология |
| Témata: | |
| On-line přístup: | https://www.pedpharma.ru/jour/article/view/1462 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
